International Physical Medicine & Rehabilitation Journal,
Journal Year:
2023,
Volume and Issue:
8(1), P. 1 - 5
Published: Jan. 1, 2023
The
coronavirus
disease
known
as
COVID-19
has
persisted
in
various
forms
now
for
three
years
without
any
major
reduction
on
its
detrimental
health
outcomes.
This
mini
review
highlights
some
aspects
of
the
condition
post-acute
or
long
syndrome
that
recently
been
seen
to
emerge
among
a
fair
percentage
survivors.
It
asks
whether
efforts
ensure
vitamin
D
intake
exposure
levels
can
impact
one
more
manifestations
way.
Using
key
words:
Vitamin
D,
Long
COVID
Post-acute
PUBMED,
PubMed
Central,
and
Google
Scholar
were
explored
articles
relevance.
Described
narrative
form,
these
data
reveal
while
this
topic
not
yet
articulated
degree
most
management
December
2022,
challenges
musculoskeletal
alone
appear
warrant
due
consideration.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(15), P. 3392 - 3392
Published: July 30, 2023
Hypovitaminosis
D
has
been
associated
with
worse
outcome
in
respiratory
tract
infections,
conflicting
opinions
regarding
its
role
Coronavirus-19
disease
(COVID-19).
Our
study
aimed
to
evaluate
the
possible
relationship
between
25-OH
vitamin
(25OHD)
values
and
following
conditions
patients
hospitalized
for
COVID-19:
prognosis,
mortality,
invasive
(IV)
non-invasive
(NIV)
mechanical
ventilation,
orotracheal
intubation
(OTI).
A
further
objective
was
analysis
of
a
positive
effect
supplementation
calcifediol
on
COVID-19
severity
prognosis.
We
analyzed
288
at
San
Giovanni
di
Dio
Hospital
Florence
Santa
Maria
alle
Scotte
Siena,
from
November
2020
February
2021.
The
25OHD
levels
correlated
positively
partial
pressure
oxygen
FiO2
(PaO2/FiO2)
ratio
(r
=
0.17;
p
<
0.05).
Furthermore,
when
we
according
type
support,
found
that
were
markedly
reduced
who
underwent
ventilation
evaluation
length
hospitalization
our
population
evidenced
longer
duration
severe
deficiency
(<10
ng/mL).
Moreover,
statistically
significant
difference
mortality
rate
had
below
10
ng/mL
those
above
this
threshold
total
(50.8%
vs.
25.5%,
0.005),
as
well
20
(38.4%
24.6%,
0.04).
supplemented
presented
significantly
(p
Interestingly,
effects
COVID-19,
percentage
deaths
higher
did
not
receive
any
than
treated
0.05)
In
conclusion,
have
demonstrated
best
prognosis
adequate
supplementation.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1910 - 1910
Published: June 17, 2024
Medical
treatment
of
coronavirus
19
disease
(COVID-19)
is
a
therapeutic
challenge.
The
available
data
strongly
suggest
that
calcifediol
may
reduce
the
severity
COVID-19,
and
corticosteroids
are
choice
worldwide
for
severe
COVID-19.
Both
have
very
similar
action
profile,
their
combined
use
in
patients
modify
contribution
each
administered
compound.
Objective:
To
evaluate
how
with
and/or
medical
practice
modified
need
ICU
admission,
death,
or
poor
prognosis
hospitalized
COVID-19
during
first
outbreaks.
Design,
setting:
A
retrospective
observational
cohort
study
admitted
to
Pneumology
Unit
Hospital
Universitario
Reina
Sofía
(Córdoba,
Spain).
Interventions:
Patients
were
treated
or/and
best
therapy
standard
care,
according
clinical
guidelines.
Measurements:
Admission
intensive
care
unit
(ICU)
death
hospitalization
prognosis.
Results:
Seven
hundred
twenty-eight
included.
According
received,
they
included
four
groups:
(n
=
68),
glucocorticoids
112),
both
510),
neither
38).
Of
578
calcifediol,
88
(15%),
while
150
not
39
required
admission
(26%)
(p
<
0.01).
Among
taking
without
glucocorticoids,
only
4
68
(5.8%)
compared
84
510
(16.5%)
0.022).
595
who
had
good
prognosis,
568
(82.01%)
received
versus
133
whom
90
(67.66%)
0.001).
This
difference
was
found
corticosteroids.
Interpretation:
moderate
mild
could
be
administering
corticosteroids,
until
natural
history
reaches
stage
hyperinflammation.
VitD
deficiency-risk
factor
pathologyHans-Klaus
Goischke
(2024)
SARS-CoV-2
Infection
and
Multiple
Sclerosis:
Proactive
Approach
in
a
Vulnerable
Patient
Group
through
Daily
Vitamin
D
Supplementation?rate
was
significantly
lower
than
with
values
below
or
deficiency
[17].Current
data
suggest
protective
role
for
VitD,
particularly
risk
of
intensive
care
unit
admission
reduced
death
[18,19].In
addition,
the
occurrence
Long-Covid
is
an
aspect
implementing
this
simple,
effective,
safe
costeffective
therapy
broad
therapeutic
window
prevention
treatment
.Although
there
still
no
indisputable
evidence
that
Vit
supplementation
(VitD
suppl.)reduces
SARSCov-2
infection
healthy
individuals,
collective
it
benefits
vulnerable
individuals
[23].PwMS
comorbidities,
psychiatric
illnesses,
hypertension,
obesity
(an
increased
BMI
may
correlate
severe
course
Covid-19),
age
>
50
years,
disability
methylprednisolone
boost
as
well
some
DMTs
(disease-modifying
therapies)
have
higher
COVID-19
courses
[24-26].Infections
(SARS-COV-2)
can
increase
MS
symptoms
(pseudo-relapses)
cause
real
relapses
[27].In
post-COVID
syndrome
(Long
Covid),
one
eight
patients
presents
such
fatigue,
shortness
breath,
cough,
joint
pain,
chest
muscle
headache
paresthesia
limbs
after
at
least
3
months.The
latter
also
occur
PwMS
per
se
[28,29].If
vitamin
administration
results
infection,
severity
illness
to
people
risk,
occurs
less
frequently
[18,19,21,22,30-33],
not
ethically
justifiable
withhold
high
dose
vitamin-D
from
risk.
Mechanisms
Action
COVID-19Barrea
et
al.
list
detail
14
mechanisms
described
by
suppl.
be
sufficient
Covid
19
vaccination
supported
[19,29,32,[34][35][36][37][38].Vit
its
metabolites
inactivate
viruses
(increase
antimicrobial
peptide
cathelicidin,
defensins),
lead
reduction
cytokine
storm,
reduce
matrix
metalloproteinase-9
concentration
thereby
host's
metabolic
tolerance
damage,
pneumonia
myocarditis,
pro-inflammatory
cytokines,
especially
interleukin
6
(IL-6),
which
promotes
permeability
BBB,
leads
potentiation
CNS
damage
PwMS,
serious
[29,[39][40][41][42].
enables
neuroprotection
reducing
inflammation
oxidative
stress.Low
25(OH)D
levels
were
inversely
correlated
IL-6
independent
predictors
mortality
[43].1,25(OH)2D3
inhibits
immunoglobulin
synthesis,
regulates
B
cell
activity
reduces
auto-Ab
production.It
converts
cells
into
plasma
[18].Vit
EBV
[29].Current
studies
show
chronic
Long
Covid-19
reactivation
latent
Epstein-Barr
virus
(EBV)
worsening
health
status
[44-48].In
MS,
level
molecular
mimicry
between
transcription
EBNA-1
protein
GlialCAM
(glial
adhesion
molecule
central
nervous
system
[49].Bernal
able
detect
detecting
DNA
antibodies
against
EBV-lytic
genes
[50].
Immunological Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 16, 2024
ABSTRACT
The
COVID‐19
pandemic
caused
by
the
SARS‐CoV‐2
virus
was
arguably
one
of
worst
public
health
disasters
last
100
years.
As
many
infectious
disease
experts
were
focused
on
influenza,
MERS,
ZIKA,
or
Ebola
as
potential
pandemic‐causing
agents,
appeared
to
come
from
nowhere
and
spread
rapidly.
with
any
zoonotic
agent,
initial
pathogen
able
transmit
a
new
host
(humans),
but
it
poorly
adapted
immune
environment
resulted
in
maladapted
response.
host‐pathogen
interaction
evolved,
subsequent
variants
became
less
pathogenic
acquired
immunity
provided
protection,
at
least
partial
variants.
has
changed
since
beginning
pandemic,
is
possible
clinical
results
discussed
here
may
not
be
applicable
today
they
start
pandemic.
With
this
caveat
mind,
we
present
an
overview
response
severe
research
perspective
examine
trials
utilizing
immunomodulating
agents
further
elucidate
importance
hyperinflammation
factor
contributing
disease.
Applied Microbiology and Biotechnology,
Journal Year:
2024,
Volume and Issue:
108(1)
Published: July 6, 2024
Abstract
Vitamin
D
deficiencies
are
linked
to
multiple
human
diseases.
Optimizing
its
synthesis,
physicochemical
properties,
and
delivery
systems
while
minimizing
side
effects
is
of
clinical
relevance
great
medical
industrial
interest.
Biotechnological
techniques
may
render
new
modified
forms
vitamin
that
exhibit
improved
absorption,
stability,
or
targeted
physiological
effects.
Novel
derivatives
hold
promise
for
developing
future
therapeutic
approaches
addressing
specific
health
concerns
related
deficiency
impaired
metabolism,
such
as
avoiding
hypercalcemic
Identifying
engineering
key
enzymes
biosynthetic
pathways
involved,
well
efficient
cultures,
therefore
outmost
importance
subject
intense
research.
Moreover,
we
elaborate
on
the
critical
role
microbial
bioconversions
might
play
in
a
la
carte
design,
production
novel,
more
efficient,
safer
analogs.
In
summary,
novelty
this
work
resides
detailed
description
physiological,
medical,
biochemical,
epidemiological
aspects
supplementation
steps
towards
enhanced
simplified
family
bioactives
relying
enzymes.
Key
points
•
Liver
kidney
pathologies
hamper
biosynthesis
Actinomycetes
able
carry
out
1α-
25-hydroxylation
precursors
World Journal of Advanced Pharmaceutical and Life Sciences,
Journal Year:
2023,
Volume and Issue:
5(2), P. 013 - 034
Published: Dec. 30, 2023
Purpose:
While
numerous
widely
accepted
nutraceuticals
lack
randomized
clinical
trial
(RCT)
validation,
regulatory
bodies
prioritize
RCTs
as
the
primary
evidence
for
testing
hypotheses
drug
approvals.
Despite
challenges
in
authorizing
generic
therapies
SARS-CoV-2,
promptly
granted
Emergency
Use
Authorization
patented
agents.
This
study
evaluated
whether
data
yielded
adequate
to
justify
approval
of
compounds,
like
vitamin
D,
adjunct
therapy
combat
SARS-CoV-2.
Methods:
We
employed
an
ancient
logic
system,
seamlessly
integrated
with
modern
scientific
principles
and
artificial
intelligence
principles,
analyze
empirical
from
7
papers
published
2020.
Subsequently,
we
compared
results
over
200
(including
100
treatment
studies)
referenced
a
large
(big)database.
aimed
determine
if
there
was
substantial
2020
support
agents
such
D
(and
ivermectin)
treating
COVID-19.
Results:
The
process
undervalues
well-designed
observational
studies,
placing
them
subordinate
position
when
assessing
effectiveness,
even
nutrients.
Our
utilization
Catuskoti,
innovative
logical
method,
highlights
its
potential
catalyst
progress,
including
big
analysis
integrating
into
nutrient
pharmaceutical
processes.
Conclusions:
Analyses
conducted
within
this
framework
affirmed
robust
inverse
correlation
between
levels
positive
outcomes
COVID-19
cases.
Emphasizing
broader
adoption
Catuskoti
logic,
particularly
analyzing
Machine
Learning
paradigms,
becomes
crucial
approach
aims
mitigate
harm
individuals
future
pandemics
by
providing
more
comprehensive
understanding
relationships
variables.
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(12), P. 2447 - 2447
Published: June 13, 2022
Calcifediol
is
the
prohormone
of
vitamin
D
endocrine
system
(VDES).
It
requires
hydroxylation
to
move
1,25(OH)2D3
or
calcitriol,
active
form
that
exerts
its
functions
by
activating
receptor
(VDR)
expressed
in
many
organs,
including
lungs.
Due
rapid
oral
absorption
and
because
it
does
not
require
first
hepatic
hydroxylation,
a
good
option
replace
prevalent
deficiency
(25
hydroxyvitamin
D;
25OHD),
which
patients
with
respiratory
pathologies
are
no
strangers.
Correcting
25OHD
can
decrease
risk
upper
infections
thus
improve
asthma
COPD
control.
The
same
happens
other
and,
particular,
COVID-19.
may
be
for
raising
serum
levels
quickly
profile
inflammatory
cytokines
exhibited
diseases,
such
as
asthma,
COVID-19,
increase
degradation
metabolites
VDES.
aim
this
narrative
revision
report
current
evidence
on
role
calcifediol
main
diseases.
In
conclusion,
status
have
beneficial
effects
clinical
course
This
hypothesis
should
confirmed
large,
randomized
trials.
Otherwise,
correction
25(OH)D
useful
disease.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Dec. 19, 2022
Existing
data
indicate
an
association
between
vitamin
D
deficiency
and
increased
severity
of
respiratory
distress
due
to
COVID-19
infection,
especially
in
high-risk
populations.
To
date,
the
effect
on
immunogenicity
SARS-CoV-2
vaccines
has
been
investigated
solely
young
healthcare
workers
a
few
studies,
yielding
conflicting
findings,
yet
highlighting
that
response
immunization
is
inversely
related
age.
Vitamin
status
can
potentially
influence
antibody
titers
people
with
previous
(or
naïve)
infection
vaccination,
given
its
role
immune
regulatory
functions.
From
this
standpoint,
supplementation
help
reduce
risk
severity/mortality
rebalance
immunological
function,
particularly
subjects
vigorous
T
lymphocyte
responses
COVID-19.
However,
more
research
needed
establish
correlation
generation
protective
serological
vaccination.
BMC Musculoskeletal Disorders,
Journal Year:
2022,
Volume and Issue:
23(1)
Published: Dec. 22, 2022
To
evaluate
the
association
of
preoperative
vitamin
D
levels
with
postoperative
hypocalcaemia
after
total
thyroidectomy.The
medical
records
patients
who
underwent
thyroidectomy
between
May
2020
and
January
2022
had
a
documented
serum
25-hydroxyvitamin
(25-OHD)
concentration
were
retrospectively
reviewed.
Vitamin
categorized
into
four
groups:
<10
ng/mL
(severe
deficiency),
10-20
(vitamin
20-30
insufficiency),
>
30
sufficiency).
Multivariate
logistic
regression
was
performed
to
analyse
risk
controlling
for
potential
confounding
factors.A
196
included
in
this
study.
Of
these,
47
(24.0%)
25-OHD
<
10
ng/mL,
62
(31.6%)
51
(26.0%)
remaining
36
(18.4%)
ng/mL.
The
incidence
hypocalcemia
highest
group
severe
deficiency
(42.6%
23.4%
laboratory
symptomatic
hypocalcaemia,
respectively),
followed
by
(29.0%
16.1%),
insufficiency
(19.6%
5.9%)
sufficiency
(5.6%
2.8%).
indicated
that
odds
13.20
times
(95%
CI:
2.69-64.79,
P
0.01)
6.32
1.32-30.28,
=
0.02)
greater
than
those
sufficiency,
respectively;
while
10.18
1.14-90.86,
0.04)
sufficiency.Preoperative
(<
20
ng/mL),
especially
is
an
independent
predictive
factor
thyroidectomy.